Cargando…

Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?

SIMPLE SUMMARY: Colorectal cancer is the third most common cancer worldwide, and approximately half of all diagnosed patients will develop liver metastases. The only curative option for colorectal liver metastases is resection. Over the last decades, liver resection for colorectal metastases has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Calderon Novoa, Francisco, Ardiles, Victoria, de Santibañes, Eduardo, Pekolj, Juan, Goransky, Jeremias, Mazza, Oscar, Sánchez Claria, Rodrigo, de Santibañes, Martín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093442/
https://www.ncbi.nlm.nih.gov/pubmed/37046774
http://dx.doi.org/10.3390/cancers15072113
_version_ 1785023587130802176
author Calderon Novoa, Francisco
Ardiles, Victoria
de Santibañes, Eduardo
Pekolj, Juan
Goransky, Jeremias
Mazza, Oscar
Sánchez Claria, Rodrigo
de Santibañes, Martín
author_facet Calderon Novoa, Francisco
Ardiles, Victoria
de Santibañes, Eduardo
Pekolj, Juan
Goransky, Jeremias
Mazza, Oscar
Sánchez Claria, Rodrigo
de Santibañes, Martín
author_sort Calderon Novoa, Francisco
collection PubMed
description SIMPLE SUMMARY: Colorectal cancer is the third most common cancer worldwide, and approximately half of all diagnosed patients will develop liver metastases. The only curative option for colorectal liver metastases is resection. Over the last decades, liver resection for colorectal metastases has been in constant evolution, and the limits of what is considered possible are continuously being pushed forward, benefiting many patients. This article sought to review the advances in the field of colorectal liver metastasis surgery and serves as a source of information for surgeons and physicians who wish to learn about all the possibilities in store for patients with colorectal liver metastases. ABSTRACT: Colorectal cancer is the third most common cancer worldwide, and up to 50% of all patients diagnosed will develop metastatic disease. Management of colorectal liver metastases (CRLM) has been constantly improving, aided by newer and more effective chemotherapy agents and the use of multidisciplinary teams. However, the only curative treatment remains surgical resection of the CRLM. Although survival for surgically resected patients has shown modest improvement, this is mostly because of the fact that what is constantly evolving is the indication for resection. Surgeons are constantly pushing the limits of what is considered resectable or not, thus enhancing and enlarging the pool of patients who can be potentially benefited and even cured with aggressive surgical procedures. There are a variety of procedures that have been developed, which range from procedures to stimulate hepatic growth, such as portal vein embolization, two-staged hepatectomy, or the association of both, to technically challenging procedures such as simultaneous approaches for synchronous metastasis, ex-vivo or in-situ perfusion with total vascular exclusion, or even liver transplant. This article reviewed the major breakthroughs in liver surgery for CRLM, showing how much has changed and what has been achieved in the field of CRLM.
format Online
Article
Text
id pubmed-10093442
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100934422023-04-13 Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go? Calderon Novoa, Francisco Ardiles, Victoria de Santibañes, Eduardo Pekolj, Juan Goransky, Jeremias Mazza, Oscar Sánchez Claria, Rodrigo de Santibañes, Martín Cancers (Basel) Review SIMPLE SUMMARY: Colorectal cancer is the third most common cancer worldwide, and approximately half of all diagnosed patients will develop liver metastases. The only curative option for colorectal liver metastases is resection. Over the last decades, liver resection for colorectal metastases has been in constant evolution, and the limits of what is considered possible are continuously being pushed forward, benefiting many patients. This article sought to review the advances in the field of colorectal liver metastasis surgery and serves as a source of information for surgeons and physicians who wish to learn about all the possibilities in store for patients with colorectal liver metastases. ABSTRACT: Colorectal cancer is the third most common cancer worldwide, and up to 50% of all patients diagnosed will develop metastatic disease. Management of colorectal liver metastases (CRLM) has been constantly improving, aided by newer and more effective chemotherapy agents and the use of multidisciplinary teams. However, the only curative treatment remains surgical resection of the CRLM. Although survival for surgically resected patients has shown modest improvement, this is mostly because of the fact that what is constantly evolving is the indication for resection. Surgeons are constantly pushing the limits of what is considered resectable or not, thus enhancing and enlarging the pool of patients who can be potentially benefited and even cured with aggressive surgical procedures. There are a variety of procedures that have been developed, which range from procedures to stimulate hepatic growth, such as portal vein embolization, two-staged hepatectomy, or the association of both, to technically challenging procedures such as simultaneous approaches for synchronous metastasis, ex-vivo or in-situ perfusion with total vascular exclusion, or even liver transplant. This article reviewed the major breakthroughs in liver surgery for CRLM, showing how much has changed and what has been achieved in the field of CRLM. MDPI 2023-04-01 /pmc/articles/PMC10093442/ /pubmed/37046774 http://dx.doi.org/10.3390/cancers15072113 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Calderon Novoa, Francisco
Ardiles, Victoria
de Santibañes, Eduardo
Pekolj, Juan
Goransky, Jeremias
Mazza, Oscar
Sánchez Claria, Rodrigo
de Santibañes, Martín
Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?
title Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?
title_full Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?
title_fullStr Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?
title_full_unstemmed Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?
title_short Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?
title_sort pushing the limits of surgical resection in colorectal liver metastasis: how far can we go?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093442/
https://www.ncbi.nlm.nih.gov/pubmed/37046774
http://dx.doi.org/10.3390/cancers15072113
work_keys_str_mv AT calderonnovoafrancisco pushingthelimitsofsurgicalresectionincolorectallivermetastasishowfarcanwego
AT ardilesvictoria pushingthelimitsofsurgicalresectionincolorectallivermetastasishowfarcanwego
AT desantibaneseduardo pushingthelimitsofsurgicalresectionincolorectallivermetastasishowfarcanwego
AT pekoljjuan pushingthelimitsofsurgicalresectionincolorectallivermetastasishowfarcanwego
AT goranskyjeremias pushingthelimitsofsurgicalresectionincolorectallivermetastasishowfarcanwego
AT mazzaoscar pushingthelimitsofsurgicalresectionincolorectallivermetastasishowfarcanwego
AT sanchezclariarodrigo pushingthelimitsofsurgicalresectionincolorectallivermetastasishowfarcanwego
AT desantibanesmartin pushingthelimitsofsurgicalresectionincolorectallivermetastasishowfarcanwego